Tag: overtreatment

Each year, hundreds of thousands of men undergo prostate biopsies triggered by PSA results—many of them unnecessary. New research shows that combining PSA testing with MRI can more accurately identify significant cancers while sparing men from needless biopsies and the harms of overtreatment. keep reading

Overtreatment of low-risk prostate cancer can leave men with lasting side effects from unnecessary whole-gland treatment. Today, advances like multiparametric MRI, active surveillance, and focal therapy are offering safer, smarter alternatives that protect health and preserve quality of life. keep reading

A groundbreaking study reveals how artificial intelligence outperforms traditional methods in prostate cancer risk stratification. By leveraging deep learning and digital biopsy data, AI enhances accuracy, reduces errors, and improves treatment planning for better outcomes. Learn how this innovative technology is transforming prostate cancer diagnosis and care. keep reading

No radiologist was born knowing how to interpret MRI scans of the prostate gland. They must be trained to interpret images, and the rate at which they improve is called their learning curve. According to Rosencrantz et al. (2017), At a basic level, by seeing many cases, radiologists experience innate self-directed visual learning, even without keep reading

Does PSA screening reduce PCa mortality, or doesn’t it? We know that PSA is not specific for cancer, since many prostate conditions can cause a rise in PSA blood levels. We also know that an elevated PSA can lead to a conventional TRUS-guided biopsy, and that such biopsies can either miss prostate cancer or... keep reading

“Cancer screening should be a regular part of your life,” states the American Cancer Society (ACS). When it comes to screening tests (e.g., Pap smear, mammogram, colonoscopy, PSA blood tests, etc.) there are two kinds of people: those who wholeheartedly embrace ACS’s advice, and those who don’t. Those in the first group believe that not keep reading

Dr. Brawley holds an important position as the chief medical officer of the American Cancer Society. As a practicing oncologist, he is considered a world cancer expert, and he is the author of “How We Do Harm: A Doctor Breaks Ranks About Being Sick In America.” So when Dr. Brawley speaks out, he’s worth listening to... keep reading

The New York Times has been called a storied U.S. media outlet. It has been awarded 137 Pulitzer Prizes since the annual prize began in 1917. Regardless of whether or not you agree with founder Adolph Ochs’ famous slogan, “All the news that’s fit to print,” it would be hard to argue with the caliber keep reading

History is littered with poor judgments, often on the part of a very small handful of people—or even a single individual. If you’re a trivia buff, you’d recognize the name of J. Bruce Ismay, owner of the Titanic, who determined a mere 20 lifeboats would be enough for an unsinkable ship. Or how about Willem keep reading

A diabetic man aged 76 with no history of prostate cancer (PCa) comes to his primary care physician (PCP) for his annual wellness visit. (Sidebar: in the good old days they were called physicals, but in today’s Medicare world, they’re annual wellness visits—and yes, there is a difference but that’s for another day.) He fasted keep reading